Aydin Huseynov

Stock Analyst at Ladenburg Thalmann

(0)
# 4572
Out of 5,240 analysts
67
Total ratings
31.58%
Success rate
-16.13%
Average return
37 Stocks
Name Action Price Target Current % Upside Ratings Updated
Marker Therapeutics
Maintains: Strong Buy
11 19
2.58 636.43% 2 Oct 21, 2024
Corvus Pharma
Maintains: Strong Buy
12 21
5.2 303.85% 3 Sep 16, 2024
Compass Therapeutics
Upgrades: Buy
5
2.13 134.74% 2 Sep 16, 2024
Acrivon Therapeutics
Upgrades: Buy
16
5.67 182.19% 3 Sep 16, 2024
Calidi Biotherapeuti...
Initiates Coverage On: Buy
10
0.92 986.96% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
24 25
12.98 92.6% 2 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 19
2.11 800.47% 2 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
4.18 4684.69% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.35 418.52% 1 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.96 410.2% 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
n/a n/a 1 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 6
0.7 757.14% 2 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 10
3.41 193.26% 3 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
375 240
1.73 13772.83% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 14
0.88 1490.91% 2 Apr 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Speculative Buy
180 80
0.83 9538.55% 1 Apr 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
4.4 354.55% 1 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
n/a n/a 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
n/a n/a 1 Aug 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.66 261.45% 1 Jul 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
5.67 270.37% 1 Jul 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
300
0.58 51624.14% 1 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
4.75 678.95% 1 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
n/a n/a 2 Feb 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
20
0.92 2073.91% 3 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
89
72.88 22.12% 2 Jul 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Speculative Buy
20
n/a n/a 1 Feb 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
n/a
n/a n/a 1 Sep 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Speculative Buy
1000
2.42 41222.31% 1 Jun 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
336
1.9 17584.21% 1 May 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
5.23 244.17% 1 Mar 19, 2020